Menu

Indian Government Aims to Take Down Predatory Journals

A government body that regulates higher education has asked universities for a “white list” of legitimate scientific journals by August 30.

Aug 29, 2018
Sukanya Charuchandra

ABOVE: ©ISTOCK, ARTISTEER

Universities in India have until August 30 to present a “white list” of recognized journals to the University Grants Commission, a government body that provides funding and maintains higher-education standards in the country. In previously submitted recommendations, universities have included predatory journals, publishers that charge high fees for low-quality or no peer review. 

“We will end this menace of predatory journals,” Prakash Javadekar, the minister of Human Resources Development for India, said during a parliamentary session last month, according to Nature

See “On Blacklists and Whitelists

Not only are several publishers of predatory journals based in India, but also a large number of the studies reported in these outlets are credited to Indian academics, reports Nature. However, researchers claim that the government’s overhaul of the academic assessment system in 2010 led to this state of affairs. The University Grants Commission’s (UGC) new format emphasized the number of publications a scientist authored and forced universities to use that productivity as a determining factor during hires and promotions. 

In January 2017, the UGC collated a white list of journals with the help of universities, but were initially unaware of the inclusion of several predatory publishers. Then in May 2018, the UGC deleted 4,305 journals from this list. 

Besides creating a white list, the government should create legislation that penalizes offending parties, suggests Bhushan Patwardhan, a biologist at Savitribai Phule Pune University, to Nature

See “Identifying Predatory Publishers

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

Horizon Discovery extends CRISPR Screening Service to primary human T cells
Horizon Discovery extends CRISPR Screening Service to primary human T cells
Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announced the extension of its CRISPR Screening Service to includeex vivoT lymphocytes. The service extension meets the requirements of immunology-based research in drug discovery,enabling new gene targets to be identified in biologically and potentially therapeutically relevant settings.
pIC50: The Advantages of Thinking Logarithmically
pIC50: The Advantages of Thinking Logarithmically
Watch this webinar from Collaborative Drug Discovery to learn about how using pIC50 helps you get a better sense of the relative potencies, calculate the correct mean of multiple values, and select better sampling doses.
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.